NMLSF (Restart Life Sciences) Buyback Yield %: 0.00 (As of Jul. 03, 2026)


What is Restart Life Sciences Buyback Yield %?

Restart Life Sciences NMLSF Buyback Yield % is 0.00 as of Jul. 03, 2026. The stock has 3 warning signs investors should review. Among 744 Biotechnology companies, Restart Life Sciences ranks worse than 134408.47% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Restart Life Sciences's current buyback yield was 0.00%.

Restart Life Sciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Restart Life Sciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Restart Life Sciences Buyback Yield % Chart

Restart Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -10.75 0.00 0.00 -26.35

Restart Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.39 -24.14 -20.34 -25.14 0.00

NMLSF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Restart Life Sciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Restart Life Sciences Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's Buyback Yield % falls into.


Restart Life Sciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Restart Life Sciences's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.206) / 4.57678104
=-26.35%

Restart Life Sciences's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 4.5505536
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Restart Life Sciences (NMLSF) has a Buyback Yield % of 0.00 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Restart Life Sciences and its competitors. According to the industry distribution chart, Restart Life Sciences ranks #999999 out of 744 companies in the Biotechnology industry.
Is Restart Life Sciences' Buyback Yield % too high?
Restart Life Sciences' current Buyback Yield % is 0.00. Based on the distribution chart, Restart Life Sciences ranks #999999 out of 744 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Restart Life Sciences' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Restart Life Sciences ranks #999999 out of 744 companies for Buyback Yield %. This places Restart Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Restart Life Sciences and its competitors. Restart Life Sciences's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Restart Life Sciences stock overvalued right now?
Restart Life Sciences (NMLSF) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Restart Life Sciences (NMLSF), the current Buyback Yield % is 0.00 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Restart Life Sciences Business Description

Other Exchanges HEAL:Canada
Address 700 - 838 West Hastings Street, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian-based life sciences company dedicated to addressing health challenges with wellness solutions. Its brands include HolyCrap, BrainQ, Brain Balls.